TY - JOUR AU - Li, Huabin AU - Chen, Shi AU - Cheng, Lei AU - Guo, Yinshi AU - Lai, He AU - Li, Yong AU - Lin, Xiaoping AU - Liu, Zheng AU - Qiu, Qianhui AU - Shao, Jie AU - Shi, Li AU - Tian, Man AU - Wang, Chengshuo AU - Wang, Hongtian AU - Wang, Xueyan AU - Wei, Qingyu AU - Wei, Yongxiang AU - Xiang, Li AU - Yang, Qintai AU - Zhao, Changqing AU - Zhang, Huanping AU - Zhi, Yuxiang AU - Gao, Junxiao AU - Li, Quansheng AU - Liu, Juan AU - Wang, Kuiji AU - Zhou, Wencheng AU - Zhang, Luo AU - Allergy (CSA), Chinese Society of PY - 2019 TI - Chinese guideline on sublingual immunotherapy for allergic rhinitis and asthma JF - Journal of Thoracic Disease; Vol 11, No 12 (December 31, 2019): Journal of Thoracic Disease Y2 - 2019 KW - N2 - The present guideline on sublingual immunotherapy (SLIT) for allergic rhinitis (AR) and allergic asthma (AS) has been developed by a panel of experts on behalf of the Chinese Society of Allergy to guide the clinical practice of SLIT in China. The panel included eminent clinical physicians and scientific specialists, who majored in the fields of Otolaryngology, Respirology, Pediatrics, Allergy and Clinical Immunology, and focused their investigations on two common allergic airway diseases (namely AR and AS) in China. During the past few decades, AR and AS have shown increasing prevalence worldwide, and resulted in substantial direct and indirect costs (1). UR - https://jtd.amegroups.org/article/view/34211